Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 7
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, Davies J, Keeble T, Mielewczik M, Kaprielian R, Malik IS, Nijjer SS, Petraco R, Cook C, Ahmad Y, Howard J, Baker C, Sharp A, Gerber R, Talwar S, Assomull R, Mayet J, Wensel R, Collier D, Shun-Shin M, Thom SA, Davies JE, Francis DP; ORBITA investigators. Al-Lamee R, et al. Lancet. 2018 Jan 6;391(10115):31-40. doi: 10.1016/S0140-6736(17)32714-9. Epub 2017 Nov 2. Lancet. 2018. PMID: 29103656 Free article. Clinical Trial.
BACKGROUND: Symptomatic relief is the primary goal of percutaneous coronary intervention (PCI) in stable angina and is commonly observed clinically. However, there is no evidence from blinded, placebo-controlled randomised trials to show its eff …
BACKGROUND: Symptomatic relief is the primary goal of percutaneous coronary intervention (PCI) in stable angi
Rethinking revascularization in patients with stable angina.
Harskamp RE, Park DW. Harskamp RE, et al. Expert Rev Cardiovasc Ther. 2018 Mar;16(3):159-161. doi: 10.1080/14779072.2018.1429915. Epub 2018 Jan 21. Expert Rev Cardiovasc Ther. 2018. PMID: 29338462 Clinical Trial.
Traditional and current perception for benefit of percutaneous coronary intervention (PCI) is that patients with stable angina will obtain symptom relief as well as improved exercise capacity after percutaneous revascularization. This com …
Traditional and current perception for benefit of percutaneous coronary intervention (PCI) is that patients with sta
The ORBITA trial: A point of view.
Oliveira VD, Giugni FR, Martins EB, Azevedo DFC, Lima EG, Serrano Júnior CV. Oliveira VD, et al. Rev Assoc Med Bras (1992). 2018 Feb;64(2):100-103. doi: 10.1590/1806-9282.64.02.100. Rev Assoc Med Bras (1992). 2018. PMID: 29641663 Free article.
Treatment of stable coronary artery disease (CAD) relies on improved prognosis and relief of symptoms. ...The ORBITA trial, recently published in an international journal, showed no benefit in terms of exercise tolerance compared to a placebo procedure in a p …
Treatment of stable coronary artery disease (CAD) relies on improved prognosis and relief of symptoms. ...The ORBITA tr …
The ORBITA Trial: What Does It Mean for Practice?
King SB 3rd. King SB 3rd. Cardiovasc Revasc Med. 2018 Jun;19(4):397-398. doi: 10.1016/j.carrev.2018.05.006. Cardiovasc Revasc Med. 2018. PMID: 29941178 No abstract available.
ORBITA - much ado about nothing?
Zaman AG. Zaman AG. J R Coll Physicians Edinb. 2018 Mar;48(1):40-43. doi: 10.4997/JRCPE.2018.109. J R Coll Physicians Edinb. 2018. PMID: 29741525 No abstract available.